No Data
No Data
No Data
No Data
No Data
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024
BRIDGEWATER, N.J., April 25, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases,
PR NewswireApr 25 08:00 ET
Express News | Insmed Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $48
Moomoo 24/7Apr 23 07:10 ET
Insmed Initiated at Buy by Truist Securities
Insmed Initiated at Buy by Truist Securities
Dow JonesApr 23 06:50 ET
Analysts Conflicted on These Healthcare Names: Cartesian Therapeutics (RNAC), Insmed (INSM) and BioNTech SE (BNTX)
TipRanksApr 23 06:40 ET
Express News | Truist Securities Initiates Coverage On Insmed With Buy Rating, Announces Price Target of $48
Moomoo 24/7Apr 23 06:40 ET
Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and UnitedHealth (UNH)
TipRanksApr 16 13:20 ET
Funhk dhat sheit : F*ck this damn nonsense
No Data
No Data